Reward learning as a potential target for pharmacological augmentation of cognitive remediation for schizophrenia: a roadmap for preclinical development

Rationale: Impaired cognitive abilities are a key characteristic of schizophrenia. Although currently approved pharmacological treatments have demonstrated efficacy for positive symptoms, to date no pharmacological treatments successfully reverse cognitive dysfunction in these patients. Cognitively-...

Descripción completa

Detalles Bibliográficos
Autores principales: Acheson, Dean T., Twamley, Elizabeth W., Young, Jared W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2013
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3684768/
https://www.ncbi.nlm.nih.gov/pubmed/23785309
http://dx.doi.org/10.3389/fnins.2013.00103

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3684768/
https://www.ncbi.nlm.nih.gov/pubmed/23785309
http://dx.doi.org/10.3389/fnins.2013.00103

Ejemplares similares